These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6482178)

  • 1. Reversible changes of tubular cell and basement membrane in drug-induced renal cystic disease.
    Kanwar YS; Carone FA
    Kidney Int; 1984 Jul; 26(1):35-43. PubMed ID: 6482178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular basement membrane change occurs pari passu with the development of cyst formation.
    Carone FA; Hollenberg PF; Nakamura S; Punyarit P; Glogowski W; Flouret G
    Kidney Int; 1989 Apr; 35(4):1034-40. PubMed ID: 2709683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane alterations during development and regression of tubular cysts.
    Ojeda JL; Ros MA; Icardo JM; García-Porrero JA
    Kidney Int; 1990 May; 37(5):1270-80. PubMed ID: 2189034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular basement membrane changes during induction and regression of drug-induced polycystic kidney disease.
    Carone FA; Butkowski RJ; Nakamura S; Polenakovic M; Kanwar YS
    Kidney Int; 1994 Nov; 46(5):1368-74. PubMed ID: 7853795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential tubular cell and basement membrane changes in polycystic kidney disease.
    Carone FA; Nakamura S; Punyarit P; Kanwar YS; Nelson WJ
    J Am Soc Nephrol; 1992 Aug; 3(2):244-53. PubMed ID: 1327261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viscoelastic properties of tubule basement membranes in experimental renal cystic disease.
    Grantham JJ; Donoso VS; Evan AP; Carone FA; Gardner KD
    Kidney Int; 1987 Aug; 32(2):187-97. PubMed ID: 3656932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basement membrane chondroitin sulfate proteoglycan alterations in a rat model of polycystic kidney disease.
    Ehara T; Carone FA; McCarthy KJ; Couchman JR
    Am J Pathol; 1994 Mar; 144(3):612-21. PubMed ID: 7510458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human polycystic and medullary cystic kidney disease with diphenylamine-induced cystic disease.
    Evan AP; Gardner KD
    Lab Invest; 1976 Jul; 35(1):93-101. PubMed ID: 940325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the collecting tubular lesion in diphenylamine-induced renal disease.
    Evan AP; Hong SK; Gardner K; Park YS; Itagaki R
    Lab Invest; 1978 Mar; 38(3):244-52. PubMed ID: 633849
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal functional changes in experimental cystic disease are tubular in origin.
    Carone FA; Ozono S; Samma S; Kanwar YS; Oyasu R
    Kidney Int; 1988 Jan; 33(1):8-13. PubMed ID: 3352161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of drug-induced renal cystic disease.
    Carone FA; Rowland RG; Perlman SG; Ganote CE
    Kidney Int; 1974 Jun; 5(6):411-21. PubMed ID: 4423327
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of nephronophthisis-cystic renal medulla complex].
    Ishii K; Kobayashi M; Koyama A; Narita M; Shigematsu H
    Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):99-103. PubMed ID: 2348578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology of cystic renal lesions. Lectin and immuno-histochemical study.
    Kovács J; Zilahy M; Gomba S
    Acta Chir Hung; 1997; 36(1-4):176-8. PubMed ID: 9408336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cystic disease induced by diphenylthiazole.
    Gardner KD; Evan AP
    Kidney Int; 1983 Jul; 24(1):43-52. PubMed ID: 6620851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased de novo synthesis of proteoglycans in drug-induced renal cystic disease.
    Lelongt B; Carone FA; Kanwar YS
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9047-51. PubMed ID: 3194406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease.
    Evan AP; Gardner KD
    Kidney Int; 1979 Jan; 15(1):7-19. PubMed ID: 491399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenylthiazole-induced changes in renal ultrastructure and enzymology: toxicologic mechanisms in polycystic kidney disease?
    Hjelle JT; Hjelle JJ; Maziasz TJ; Carone FA
    J Pharmacol Exp Ther; 1987 Nov; 243(2):758-66. PubMed ID: 3119818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
    Rankin CA; Suzuki K; Itoh Y; Ziemer DM; Grantham JJ; Calvet JP; Nagase H
    Kidney Int; 1996 Sep; 50(3):835-44. PubMed ID: 8872958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron microscopy of nephropathia epidemica. Renal tubular basement membrane.
    Collan Y; Lähdevirta J; Jokinen EJ
    Am J Pathol; 1978 Jul; 92(1):167-72. PubMed ID: 28673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal mesenchymal tumours induced in rats by dimethylnitrosamine: light- and electron-microscope studies.
    Ireton HJ; McGiven AR; Davies DJ
    J Pathol; 1972 Nov; 108(3):181-5. PubMed ID: 4119086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.